W. Mark Eickhoff
15Patents
11h-index
19Co-inventors
69Inventor score
Filing activity: Dec 30, 1994 → Sep 19, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5580579A | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers | Emerging Cross-Sectional Technologies | 139 | Expired |
| US5560931A | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids | Human Necessities | 138 | Expired |
| US5571536A | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids | Emerging Cross-Sectional Technologies | 124 | Expired |
| US5518738A | Nanoparticulate nsaid compositions | Human Necessities | 124 | Expired |
| US6432381B1 | Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract | Emerging Cross-Sectional Technologies | 107 | Expired |
| US5585108A | Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays | Human Necessities | 106 | Expired |
| US5466440A | Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays | Performing Operations; Transporting | 56 | Expired |
| US5628981A | Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents | Emerging Cross-Sectional Technologies | 53 | Expired |
| US5503723A | Isolation of ultra small particles | Emerging Cross-Sectional Technologies | 47 | Expired |
| US5593657A | Barium salt formulations stabilized by non-ionic and anionic stabilizers | Emerging Cross-Sectional Technologies | 46 | Expired |
| US10117836B2 | Tablet formulation for CGRP active compounds | Human Necessities | 12 | Active |
| US11925709B2 | Tablet formulation for CGRP active compounds | Human Necessities | 9 | Active |
| US12220408B2 | Treatment of migraine | Human Necessities | 2 | Active |
| US12168004B2 | Treatment of migraine | Human Necessities | 2 | Active |
| US12310953B2 | Pharmaceutical formulations for the treatment of migraine | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.